Speciality: Infectious diseases
Description:
A warm welcome to all the medical professionals in this interesting session on You might know this as Long COVID. - By Dr. Ashwini Avashiti.
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), refers to a range of symptoms that persist for weeks or months after the acute phase of a COVID-19 infection has resolved. Dr. Ashwini Avashiti explains that individuals with Long COVID may experience a variety of lingering symptoms, including fatigue, shortness of breath, cognitive difficulties often termed "brain fog," chest pain, and joint or muscle pain. These symptoms can fluctuate in intensity and may impact multiple organ systems, significantly affecting the quality of life.
Dr. Avashiti notes that while the exact mechanisms behind Long COVID are not fully understood, potential causes include ongoing inflammatory responses, immune system dysregulation, and residual viral particles. The condition can affect anyone who has had COVID-19, regardless of the severity of their initial illness. Diagnosis is primarily based on patient history and symptom presentation, as there are no specific tests for Long COVID.
Management of Long COVID often involves a multidisciplinary approach, including physical therapy, cognitive rehabilitation, and symptom-specific treatments. Dr. Avashiti emphasizes the importance of personalized care and ongoing research to better understand and treat this complex condition, as well as support for patients through dedicated Long COVID clinics and support groups.
Therefore, get an overall knowledg
See More Webinars @ Hidoc Webinars
1.
Physician Fights Insurer to Cover Her Baby's Brain Cancer Treatment
2.
A small rise in cancer was observed following the 1986 Chernobyl accident.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
New research uncovers link between cancer pathway and blood-retina barrier function
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians
2.
Survivorship Planning Beyond Active Cancer Care
3.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
4.
Integrated Models in Hematology for Specialists
5.
Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation